590 related articles for article (PubMed ID: 9851826)
1. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
Condino-Neto A; Newburger PE
Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down-regulating expression of genes encoding oxidase components.
Condino-Neto A; Whitney C; Newburger PE
J Immunol; 1998 Nov; 161(9):4960-7. PubMed ID: 9794432
[TBL] [Abstract][Full Text] [Related]
3. Induction of expression of genes encoding components of the respiratory burst oxidase during differentiation of human myeloid cell lines induced by tumor necrosis factor and gamma-interferon.
Gupta JW; Kubin M; Hartman L; Cassatella M; Trinchieri G
Cancer Res; 1992 May; 52(9):2530-7. PubMed ID: 1568222
[TBL] [Abstract][Full Text] [Related]
4. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
[TBL] [Abstract][Full Text] [Related]
5. Partial reconstitution of the respiratory burst oxidase in lymphoblastoid B cell lines lacking p67-phox after transfection with an expression vector containing wild-type and mutant p67 -phox cDNAs: Deletions of the carboxy and amino terminal residues of p67-phox are not required for activity.
Chanock SJ; Faust LR; Barrett D; Christensen B; Newburger PE; Babior BM
Exp Hematol; 1996 Mar; 24(4):531-6. PubMed ID: 8608803
[TBL] [Abstract][Full Text] [Related]
6. Human peripheral eosinophils have a specific mechanism to express gp91-phox, the large subunit of cytochrome b558.
Kuribayashi F; Kumatori A; Suzuki S; Nakamura M; Matsumoto T; Tsuji Y
Biochem Biophys Res Commun; 1995 Apr; 209(1):146-52. PubMed ID: 7726828
[TBL] [Abstract][Full Text] [Related]
7. Chronic granulomatous disease: towards gene therapy.
Thrasher A; Segal A; Casimir C
Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
[TBL] [Abstract][Full Text] [Related]
8. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
Maly FE; Cross AR; Jones OT; Wolf-Vorbeck G; Walker C; Dahinden CA; De Weck AL
J Immunol; 1988 Apr; 140(7):2334-9. PubMed ID: 2832475
[TBL] [Abstract][Full Text] [Related]
9. New insights into the membrane topology of the phagocyte NADPH oxidase: characterization of an anti-gp91-phox conformational monoclonal antibody.
Campion Y; Paclet MH; Jesaitis AJ; Marques B; Grichine A; Berthier S; Lenormand JL; Lardy B; Stasia MJ; Morel F
Biochimie; 2007 Sep; 89(9):1145-58. PubMed ID: 17397983
[TBL] [Abstract][Full Text] [Related]
10. Low NADPH oxidase activity in Epstein-Barr-virus-immortalized B-lymphocytes is due to a post-transcriptional block in expression of cytochrome b558.
Chetty M; Thrasher AJ; Abo A; Casimir CM
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):141-5. PubMed ID: 7864801
[TBL] [Abstract][Full Text] [Related]
11. Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression.
Levy R; Rotrosen D; Nagauker O; Leto TL; Malech HL
J Immunol; 1990 Oct; 145(8):2595-601. PubMed ID: 2170520
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of NADPH oxidase components and increased production of interferon-gamma by leukocytes from sickle cell disease patients.
Marçal LE; Dias-da-Motta PM; Rehder J; Mamoni RL; Blotta MH; Whitney CB; Newburger PE; Costa FF; Saad ST; Condino-Neto A
Am J Hematol; 2008 Jan; 83(1):41-5. PubMed ID: 17654682
[TBL] [Abstract][Full Text] [Related]
13. Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly.
Li XJ; Fieschi F; Paclet MH; Grunwald D; Campion Y; Gaudin P; Morel F; Stasia MJ
J Leukoc Biol; 2007 Jan; 81(1):238-49. PubMed ID: 17060362
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and immunochemical properties of B lymphocyte cytochrome b558.
Batot G; Paclet MH; Doussière J; Vergnaud S; Martel C; Vignais PV; Morel F
Biochim Biophys Acta; 1998 Mar; 1406(2):188-202. PubMed ID: 9573361
[TBL] [Abstract][Full Text] [Related]
15. Taurine chloramine inhibits PMA-stimulated superoxide production in human neutrophils perhaps by inhibiting phosphorylation and translocation of p47(phox).
Choi HS; Cha YN; Kim C
Int Immunopharmacol; 2006 Sep; 6(9):1431-40. PubMed ID: 16846837
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
[TBL] [Abstract][Full Text] [Related]
17. Mutation at histidine 338 of gp91(phox) depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase.
Yoshida LS; Saruta F; Yoshikawa K; Tatsuzawa O; Tsunawaki S
J Biol Chem; 1998 Oct; 273(43):27879-86. PubMed ID: 9774399
[TBL] [Abstract][Full Text] [Related]
18. Absence of both subunits of cytochrome b558 in the UM384 cell line relative to the inability to generate superoxide anions.
Champelovier P; Laporte F; Verhoeven AJ; Hilarius P; de Klein A; Revol C; Seigneurin D; Kolodie L
Exp Hematol; 1993 Jul; 21(7):885-92. PubMed ID: 8391470
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients.
Dusi S; Nadalini KA; Donini M; Zentilin L; Wientjes FB; Roos D; Giacca M; Rossi F
J Immunol; 1998 Nov; 161(9):4968-74. PubMed ID: 9794433
[TBL] [Abstract][Full Text] [Related]
20. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
Nunoi H; Ishibashi F
Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
